Filana Therapeutics (FLNA) Interest Coverage Ratio (2022 - 2026)
Filana Therapeutics (FLNA) posted Interest Coverage Ratio of 57.27 for Q2 2026, down 5.65% on a QoQ basis from 54.21 in Q1 2026, and up 80.32% year-over-year from 31.76 in Q2 2025.
Powered by 
Analysis
Filana Therapeutics (FLNA) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Filana Therapeutics has reported Interest Coverage Ratio for 5 years, with the latest figure at 57.27 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 80.32% year-over-year to 57.27 in Q2 2026; TTM through Jun 2026 was 62.8, a 63.89% increase from a year earlier, with the FY2025 full-year figure at 96.84, up 8.26% from the prior year.
- Interest Coverage Ratio was 57.27 for Q2 2026 at Filana Therapeutics, down from 54.21 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 48.69 in Q4 2022, with the low at 290.97 in Q2 2025.
- Average Interest Coverage Ratio over 5 years is 105.64, with a median of 77.61 recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Interest Coverage Ratio sank 253.3% in 2024, then soared 80.32% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 48.69 in 2022, then slumped by 59.74% to 77.78 in 2023, then sank by 154.44% to 197.9 in 2024, then jumped by 48.12% to 102.67 in 2025, then surged by 44.21% to 57.27 in 2026.
- The last three Interest Coverage Ratio figures came in at 57.27 (Q2 2026), 54.21 (Q1 2026), and 102.67 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | -57.27 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -57.27 |
| Mar 31, 2026 | -54.21 |
| Dec 31, 2025 | -102.67 |
| Sep 30, 2025 | -51.57 |
| Jun 30, 2025 | -290.97 |
| Mar 31, 2025 | -113.30 |
| Dec 31, 2024 | -197.90 |
| Sep 30, 2024 | -135.50 |
| Jun 30, 2024 | -285.59 |
| Mar 31, 2024 | -82.03 |
| Dec 31, 2023 | -77.78 |
| Sep 30, 2023 | -77.44 |
| Jun 30, 2023 | -80.83 |
| Mar 31, 2023 | -72.24 |
| Dec 31, 2022 | -48.69 |
| Sep 30, 2022 | -52.06 |
| Jun 30, 2022 | -64.04 |
| Mar 31, 2022 | -57.49 |